ArticleDrug design, development and therapy2017

An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.

Tomer Meirson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.